Apeloa Pharmaceutical Co

Apeloa Pharmaceutical Co P/CF

The P/CF (Price-to-Cash-Flow Ratio) of Apeloa Pharmaceutical Co (000739.SZ) as of Oct 18, 2026 is 17.22. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was 17.53 — a change of -1.78% (lower).

P/CF

17.22

YoY

-1.78%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Apeloa Pharmaceutical Co is 2025 17.22 . P/CF (Price-to-Cash-Flow Ratio) of Apeloa Pharmaceutical Co was 2024 17.53 . It decreases by -1.78% lower compared to the previous year.

The Apeloa Pharmaceutical Co P/CF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/CF
Date
P/CF
Jan 1, 2018
25.45 CNY
Jan 1, 2019
15.58 CNY
Jan 1, 2020
20.00 CNY
Jan 1, 2021
34.64 CNY
Jan 1, 2022
15.98 CNY
Jan 1, 2023
20.54 CNY
Jan 1, 2024
17.53 CNY
Jan 1, 2025
17.22 CNY
The Apeloa Pharmaceutical Co P/CF history
YEARP/CFYoY
17.22-1.78%
17.53-14.68%
20.54+28.58%
15.98-53.87%
34.64+73.20%
20.00+28.37%
15.58-38.78%
25.45-74.80%
100.99-14.00%
117.44+144.52%
48.03+78.31%
26.93—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Apeloa Pharmaceutical Co Stock analysis

What does Apeloa Pharmaceutical Co do? Apeloa Pharmaceutical Co Ltd, headquartered in Jinhua, Zhejiang, operates in the Health Care sector, specializing in pharmaceuticals. The company develops and produces active pharmaceutical ingredient (API) intermediates, offers contract development and production services (CDMO), and manufactures bulk drugs, chemical preparations, and traditional Chinese medicine formulations such as ubenimex capsules and cefixime. With 6,791 employees, it serves domestic and international markets, focusing on research, development, and production within the pharmaceutical industry. Apeloa Pharmaceutical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Apeloa Pharmaceutical Co stock

P/CF (Price-to-Cash-Flow Ratio) of Apeloa Pharmaceutical Co is 17.22 in 2025.

P/CF (Price-to-Cash-Flow Ratio) of Apeloa Pharmaceutical Co changed from 17.53 to 17.22, representing a -1.78% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) Apeloa Pharmaceutical Co since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s Apeloa Pharmaceutical Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Apeloa Pharmaceutical Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Apeloa Pharmaceutical Co